436.45
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Better Bet Than Amgen Stock: INCY, NBIX Deliver More - Trefis
NewEdge Wealth LLC Reduces Holdings in Amgen Inc. $AMGN - MarketBeat
Main Street Financial Solutions LLC Takes $1.66 Million Position in Amgen Inc. $AMGN - MarketBeat
Wealthfront Advisers LLC Sells 6,410 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Great Lakes Advisors LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by Danske Bank A S - MarketBeat
First National Bank of Omaha Has $15.65 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc (AMGN) Shares Surge 4.0% -- What GF Score of 79 Tells Investors - GuruFocus
Amgen abandoning $500M+ Crohn’s collab won’t derail TScan’s pipeline strategy - Fierce Biotech
Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen? - 24/7 Wall St.
Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know - TradingKey
Amgen Stock Surges 3.5% as Healthcare Hits Record High - Yahoo Finance
Amgen cans its TScan partnership; Amylyx reveals $350M offering - Endpoints News
Argus Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - MarketBeat
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up? - The Motley Fool
Amgen Inc. $AMGN Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Trust Co. of Vermont Purchases New Position in Amgen Inc. $AMGN - MarketBeat
ETFs Investing in Amgen Inc. Stocks - TradingView
Pharma in hackers' crosshairs as Amgen breach moves to courts - The Pharma Letter
Commerzbank Aktiengesellschaft FI Acquires 14,693 Shares of Amgen Inc. $AMGN - MarketBeat
AMG National Trust Bank Has $3.57 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen stock extends 2026 rally as Q2 earnings beat and guidance lifted - Ad-hoc-news.de
ANTITRUST NEWS—4th Cir.: FTC: Amgen’s Enbrel patent-application deal is subject to antitrust scrutiny - vitallaw.com
TScan TherapeuticsAmgen To Terminate Research Collaboration And License Agreement With TScan TherapeuticsSEC Filing - TradingView
TScan (NASDAQ: TCRX) loses Amgen Crohn’s collaboration - Stock Titan
Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Can Amgen (NASDAQ:AMGN) Extend Its Record-High Momentum? - Kalkine Media
Amgen (NASDAQ:AMGN) Results Put Growth Back In Focus - Kalkine Media
The Bull Case For Amgen (AMGN) Could Change Following Raised 2026 Earnings Guidance And Q2 BeatLearn Why - simplywall.st
Cantor Fitzgerald raises Amgen stock price target on core portfolio strength - Investing.com India
Amgen (NASDAQ:AMGN) Reaches New 1-Year High on Analyst Upgrade - MarketBeat
Amgen stock hits all-time high at 422.49 USD - Investing.com
Amgen stock hits all-time high at 422.49 USD By Investing.com - Investing.com India
Resilient Amgen stock trades above $419 as earnings beat and 2026 guidance support momentum - AD HOC NEWS
Amgen (NASDAQ:AMGN) Given New $352.00 Price Target at Mizuho - MarketBeat
Cantor Fitzgerald Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
AMGN Maintains by Cantor Fitzgerald -- Price Target Raised to $4 - GuruFocus
Wilkinson Global Asset Management LLC Lowers Holdings in Amgen Inc. $AMGN - MarketBeat
Russell Investments Group Ltd. Sells 37,910 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Kinsale Capital Group Inc. - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Purchases 5,903 Shares of Amgen Inc. $AMGN - MarketBeat
Kelleher Financial Advisors Buys 2,580 Shares of Amgen Inc. $AMGN - MarketBeat
Jessica Merrill: Mid-Cap Biopharma's $1B-Plus Deal Surge Could Spawn the Next Amgen - finance.biggo.com
Global Retirement Partners LLC Takes $8.88 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen stock holds above $415 as Q2 2026 growth and guidance support valuation - AD HOC NEWS
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
Mizuho Securities Adjusts Amgen Price Target to $352 From $303 - marketscreener.com
Amgen stock holds firm after Q2 sales raised the bar - ad-hoc-news.de
AMGN DCF Analysis: Intrinsic Value $296 vs Price $415 - GuruFocus
KBC Group NV Acquires 130,497 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Janney Montgomery Scott LLC - MarketBeat
Amgen Inc. $AMGN Stock Holdings Lessened by Fifth Third Bancorp - MarketBeat
Amgen Inc. $AMGN Shares Bought by Bridgewater Advisors Inc. - MarketBeat
111 Capital Has $1.40 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen stock holds steady as analyst lifts price target on obesity drug focus - AD HOC NEWS
Should Income Investors Look At Amgen Inc. (NASDAQ:AMGN) Before Its Ex-Dividend? - simplywall.st
Amgen Inc. $AMGN Shares Sold by Strive Financial Group LLC - MarketBeat
Principal Financial Group Inc. Decreases Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co. - MarketBeat
TD Asset Management Inc Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Commonwealth Retirement Investments LLC Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
TCW Group Inc. Has $10.27 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Hussman Strategic Advisors Inc. Has $3.04 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Jennison Associates LLC Purchases 75,212 Shares of Amgen Inc. $AMGN - MarketBeat
Vontobel Holding Ltd. Acquires 4,637 Shares of Amgen Inc. $AMGN - MarketBeat
Elyxium Wealth LLC Has $5.16 Million Holdings in Amgen Inc. $AMGN - MarketBeat
GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk) - Currently.com
Garabedian on Biotech's Post-Deal 'Shoes That Drop': Seven Vykat XR Deaths and Amgen's Tavneos Pull - finance.biggo.com
AMGN Maintained by Barclays -- Price Target Raised to $380 - GuruFocus
Amgen stock holds near 52-week high after earnings beat and insider sale - ad-hoc-news.de
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):